Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder - The spontaneously hypertensive rat

Metabolic Brain Disease

Volumn 23, Issue 3, 2008, Pages 303-314

  Soeters, Heleen Suzanne ^a   Howells, Fleur Margaret ^a   Russell, Vivienne Ann ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Addiction; Alcohol; Dopamine; Locomotor activity; SHR; WKY

Indexed keywords

ALCOHOL; METHYLPHENIDATE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL STAGE; DISEASE PREDISPOSITION; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; WISTAR KYOTO RAT;

ALCOHOL DRINKING; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; METHYLPHENIDATE; MOTOR ACTIVITY; NEOSTRIATUM; POTASSIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPECIES SPECIFICITY;

RATTUS;

EID: 50049087522     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-008-9098-1     Document Type: Article

References (35)

1. Bailey CP, O'Callaghan MJ, Croft AP, Manley SJ, Little HJ (2001) Alterations in mesolimbic dopamine function during the abstinence period following chronic alcohol consumption. Neuropharmacology 41:989-999
2. Brandon CL, Marinelli M, Baker LK, White FJ (2001) Enhanced reactivity and vulnerability to cocaine following low dose exposure to methylphenidate in adolescent rats. Neuropsychopharmacology 25:651-661
3. Carlezon WA, Mague SD, Andersen SL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54:1330-1337
4. Cierpial MA, Shasby DE, Murphy CA, Borom AH, Stewart RE, Swithers SE, McCarty R (1989) Open-field behavior of spontaneously hypertensive and Wistar-Kyoto normotensive rats: effects of Reciprocal Cross-Fostering. Behav and Neural Biol 51:203-210
5. Da Silva GE, Ramos A, Takahashi RN (2004) Comparison of voluntary ethanol intake by two pairs of rat lines used as genetic models of anxiety. Brazil Med Biol Res 37:1511-1517
6. Da Silva GE, Vendruscolo LF, Takahashi RN (2005) Effects of ethanol on locomotor and anxiety-like behaviors and the acquisition of ethanol intake in Lewis and spontaneously hypertensive rats. Life Sci 77:693-706
7. 99mTc] TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Euro Nucl Med 27:1518-1524
8. Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention deficit-hyperactivity disorder. N Engl J Med 340:780-788
9. Gatley SJ, Volkow ND, Grifford AN, Fowler JS, Dewey SL, Ding YS, Logon J (1999) Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146:93-100
10. Gayton O, Yang P, Swann A, Dafny N (2000) Diurnal differences in sensitization to methylphenidate. Brain Res 864:24-39
11. Kirouac GJ, Ganguly PK (1992) Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience 52:135-141
12. Kollins SH (2003) Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry 64:14-18
13. Kuczenski R, Segal DS (2005) Stimulant action in rodents: implications for attention-deficit/ hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57:1391-1396
14. Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999) Neuronal nicotinic acetylcholine receptors: a new target site for ethanol. Neurochem Internat 35:131-141
15. Nestby P, Vanderchuuren LJMJ, De Vries TJ, Mulder AH, Wardeh G, Hogenboom F, Schoffelmeer ANM (1999) Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen. Psychopharmacology 141:307-314
16. Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293
17. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th edn. Elsevier Academic, New York
18. Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:227-86
19. Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A (2005) Methylphenidate- evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. NeuroImage 25:868-876
20. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1995) Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Brain Res 676:343-351
21. 3H] dopamine and [14C] acetylcholine release from rat prefrontal cortex, nucleus accumbens and caudate-putamen slices. Neurosci Prot 96-060-05-01-18
22. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94:163-171
23. Russell VA, de Villiers AS, Sagvolden T, Lamm MCL, Taljaard JJF (2000) Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder-the spontaneously hypertensive rat. Brain Res Bull 53:187-192
24. Russell VA, Sagvolden T, Johansen EB (2005) Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 1:1-17
25. Sagvolden T (2000) Behavioural validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39
26. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent Models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239-1247
27. Seeman P, Madras B (2002) Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 130:70-83
28. Söderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113:85-98
29. Stromberg MF, Volpicelli JR, O'Brian CP (1998) Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res 22:2186-2191
30. Sue D, Sue DW, Sue S (2000) Disorders of childhood. Understanding abnormal behaviour, 6th edn. Houghton Mifflin Company, New York, pp 478-515
31. Valenzuela CF (1997) Alcohol neurotransmitter interactions. Alcohol Health Res World 21:144-148
32. Volkow ND, Insel TR (2003) What are the long-term effects of methylphenidate treatment? Biol Psychiatry 54:1307-1309
33. Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding YS, Gatley SJ, Grifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Neuroscience 21:1-5
34. Wheeler TL, Eppolito AK, Smith LN, Huff TB, Smith RF (2007) A novel method for oral stimulant administration in the neonate rat and similar species. J Neurosci Methods 159:282-285
35. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179-185